Target intelligence / Profile preview

Long intergenic non-protein coding RNA 3094 (LINC03094)

Target
LINC03094
Molecular classification
Long non-coding RNA (lncRNA), Long intergenic non-coding RNA (lincRNA)
01

Overview

Long intergenic non-protein coding RNA 3094 (LINC03094, also known as lnc-SMC2-1) is classified as a **long intergenic non-coding RNA (lincRNA)**, a class of RNA transcripts longer than 200 nucleotides that do not code for proteins and are transcribed from genomic regions between known protein-coding genes[1][3][5][7][9]. LINC03094 is catalogued in multiple gene databases, including NCBI Gene (101928523), Ensembl (ENSG00000285483), and HGNC (56725)[1][3][5][7][9]. It is a member of the lncRNA/lincRNA family, which is increasingly recognized for roles in the regulation of gene expression, modulation of chromatin structure, and interaction with other RNAs and proteins[10]. Though specific functional or disease-related data for LINC03094 itself are not available in major resources, other lincRNAs often participate in biologically significant processes such as cell cycle, apoptosis, and immune response, and have been associated with various human cancers—frequently as regulators rather than direct therapeutic targets[10]. **LINC03094 is not a classical therapeutic target** (such as an enzyme, receptor, or transporter) and there is no reported evidence of interacting drugs or validated use as a biomarker. Its aliases include lnc-SMC2-1, and it appears in multiple transcriptomic databases under different accession numbers and synonyms[1][5][9]. At present, there is no indication of misspelling, incorrect classification, or major ambiguities associated with this gene.

Other names
lnc-SMC2-1LNC03094ENSG00000285483HGNC:56725101928523
02

Biological functions

Gene expression regulationPotential involvement in cell cyclePotential involvement in cell survivalPotential involvement in immune response
03

Disease associations

Cancer (lncRNAs in this class frequently show differential expression or functional roles in cancers, but no direct evidence links LINC03094 specifically to a disease)

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 3094 (LINC03094).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 3094 (LINC03094).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call